Medical assessment of adverse health outcomes in Dutch childhood cancer survivors; a nationwide project; SKION LATER Q2008 - Metabolic syndrome parameters in adult survivors of childhood cancer

Completed

• Conditions: adiposity; high bloodpressure; 10018424; 10000546

• Registration Number: NL-OMON47840
• Lead Sponsor: Stichting Kinderoncologie Nederland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 5000

Inclusion Criteria

All patients who were treated for childhood cancer (before age 18) in one of
the Pediatric Oncology Centers between 1960 and 2004 and who survived for at
least 5 years after diagnosis will be included in the SKION LATER- metabolic
syndrome study. Participating centres are located in Amsterdam (VU University
Medical Center (VUMC)), Groningen (Children's Cancer Center/ University Medical
Center Groningen (UMCG)), Rotterdam (Rotterdam Erasmus MC-Sophia (REMC-S),
Nijmegen (University Medical Center Nijmegen (UMCN)), Leiden (Leiden University
Medical Center (LUMC) and Utrecht (Princess Máxima Center for Pediatric
Oncology (PMC)).

Exclusion Criteria

diagnosis of childhood cancer with survival less than 5 years, age at diagnosis
>17 years or diagnosis while residing in foreign country

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Prevalence of metabolic syndrome or its denominators (body composition,<br /><br>hypertension, DM, Fat spectrum)</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>nvt</p><br>